Significant predictors of preference for inhaled versus injectable insulin in patients with type 2 diabetes

被引：0

作者：

Hayes, R. P. ^{[1
]}

Stump, T. E. ^{[1
]}

Muchmore, D. B. ^{[1
]}

Schmitkel, J. ^{[1
]}

机构：

[1] Eli Lilly & Co, Indianapolis, IN 46285 USA

来源：

DIABETOLOGIA | 2007年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0974

引用

页码：S402 / S402

页数：1

共 50 条

[31] Inhaled insulin (Exubera®) leads to a greater potential acceptance of insulin therapy in patients with uncontrolled type 2 diabetes
Freemantle, N
Blonde, L
Bolinder, B
Hompesch, M
Duhot, D
Eggertsen, R
Hobbs, FDR
Martinez, L
Ross, S
Stridde, E
DIABETES, 2004, 53 : A466 - A466
[32] Insulin analogs versus human insulin in type 2 diabetes
Migdalis, Ilias N.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 : S102 - S104
[33] The availability of inhaled insulin leads to improved health outcomes in patients with uncontrolled Type 2 diabetes
Blonde, L
Freemantle, N
Ross, SA
Bolinder, B
Gerber, RA
DIABETOLOGIA, 2004, 47 : A310 - A310
[34] Initiation of Prandial Insulin Therapy with AIR Inhaled Insulin or Insulin Lispro in Patients with Type 2 Diabetes: A Randomized Noninferiority Trial
Gross, Jorge L.
Nakano, Masako
Colon-Vega, Gildred
Ortiz-Carasquillo, Ramon
Ferguson, Jeffrey A.
Althouse, Sandra
Tobian, Janet A.
Berclaz, Pierre-Yves
Milicevic, Zvonko
DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 : S27 - S34
[35] Psychological Insulin Resistance in Type 2 Diabetes Patients Regarding Oral Antidiabetes Treatment, Subcutaneous Insulin Injections, or Inhaled Insulin
Petrak, Frank
Herpertz, Stephan
Stridde, Elmar
Pfuetzner, Andreas
DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (08) : 702 - 710
[36] Predictors of switching to insulin from non-insulin therapy in patients with type 2 diabetes mellitus
Janghorban, Mohsen
Amini, Masoud
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (01) : 111 - 117
[37] Can inhaled insulin improve glycemic control of type 2 diabetes?
Pendergrass, M
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (06): : 308 - 309
[38] Patient Reported Outcomes in Adults with Type 2 Diabetes Using Mealtime AFRESA™ (Inhaled Technosphere® Insulin) and Basal Insulin Versus Premixed Insulin
Howard, Campbell P.
Rubin, Richard R.
Peyrot, Mark
DIABETES, 2009, 58 : A148 - A148
[39] Can inhaled insulin improve glycemic control of type 2 diabetes?
Merri Pendergrass
Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 308 - 309
[40] Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes
Quattrin, T
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (12) : 2597 - 2604

← 1 2 3 4 5 →